UBS AM’s DURECT Corp DRRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-21,571
Closed -$276K 2866
2021
Q3
$276K Hold
21,571
﹤0.01% 2634
2021
Q2
$352K Buy
21,571
+1,201
+6% +$20.9K ﹤0.01% 2616
2021
Q1
$403K Buy
20,370
+3,440
+20% +$77.3K ﹤0.01% 2446
2020
Q4
$350K Buy
16,930
+2,760
+19% +$52.5K ﹤0.01% 2388
2020
Q3
$242K Buy
14,170
+1,360
+11% +$27.3K ﹤0.01% 2355
2020
Q2
$297K Buy
+12,810
New +$282K ﹤0.01% 2287

Other funds holding DRRX

UBS AM's DRRX Position: Q4 2021 in Review

UBS AM sold out of DURECT Corp (DRRX) in Q4 2021, closing a stake of 21,571 shares — an estimated $276K sold.

UBS AM first reported a position in DRRX in Q2 2020 and held it in 6 quarters. The position peaked at $403K in Q1 2021. 101 funds tracked by Wall St. Rank hold DRRX as of Q4 2021.

  • UBS AM reported no remaining DURECT Corp position as of Q4 2021 after selling out during the quarter.
  • UBS AM sold 21,571 DURECT Corp shares in Q4 2021, an estimated $276K.
  • UBS AM first reported a position in DURECT Corp in Q2 2020 and held it in 6 quarters.
  • UBS AM's DURECT Corp position peaked at $403K in Q1 2021.
  • 101 funds tracked by Wall St. Rank held DURECT Corp as of Q4 2021.

Based on UBS AM's 13F filing for Q4 2021, filed 14 Feb 2022.